Name: 글로벌 시장 동향
SKU: MD7193
Availability: InStock

보고서 요약(국문)

개요
전 세계 카날로플라스티 치료 시장은 2022년 YY백만 달러에 도달했으며, 2023년부터 2030년까지 연평균 성장률(CAGR) YY%로 성장하여 2030년에는 YY백만 달러에 이를 것으로 예상됩니다.
카날로플라스티는 안압 상승으로 시신경이 손상되어 시력 손실을 초래할 수 있는 안과 질환인 녹내장을 치료하는 데 사용되는 수술입니다. 카날로플라스티의 주요 목표는 녹내장에서 시신경 손상 및 진행성 시력 손실의 주요 위험 요인인 높은 안압을 낮추는 것입니다. 눈의 자연 배수 시스템을 확장하고 막힌 부분을 뚫어줌으로써 카날로플라스티는 안압을 효과적으로 낮추고 시력을 보존하는 데 도움을 줄 수 있습니다.
카날로플라스티로 인한 장기적인 안압 감소는 환자들이 추가 시술을 피하거나 지연시키고, 잦은 약물 변경의 필요성을 줄이는 데 도움이 될 수 있습니다. 약물 치료에도 효과를 보지 못하고 수술적 치료를 고려하는 경증에서 중등도 개방각 녹내장 환자를 포함한 다양한 환자에게 카날로플라스티는 효과적인 치료법이 될 수 있습니다. 보다 침습적인 수술과 관련된 위험을 줄이고자 하는 환자들도 카날로플라스티를 선택할 수 있습니다.
시장 동향: 성장 동인 및 제약 요인
기업들의 전략
기업들의 신제품 출시 및 기술 개발과 같은 전략은 시장 성장을 가속화합니다. 예를 들어, 노바 아이 메디컬 리미티드(Nova Eye Medical Limited)는 2022년 4월 차세대 카날로플라스티 장비인 iTrack Advance를 유럽 및 아시아 일부 지역에 출시했습니다. iTrack Advance의 출시는 카날로플라스티 분야 확장에 대한 당사의 노력을 보여줍니다. 회사는 iTrack Advance 출시로 인해 카날로플라스티 시술을 시행하는 백내장 전문의 및 일반 안과의사의 수가 증가할 것으로 기대합니다.

전 세계 카날로플라스티 시장 매출 성장을 견인하는 주요 요인 중 하나는 녹내장 환자 수의 증가입니다. 녹내장은 통증이 없는 안과 질환으로, 상당한 시력 손실이 발생하기 전까지는 증상이 나타나지 않기 때문에 환자 수가 주기적으로 증가하고 있습니다. 따라서 이러한 요인들이 시장 성장을 촉진하고 있습니다.
시장 동향: 제약 요인
카날로플라스티는 여러 가지 긍정적인 효과를 가지고 있지만, 널리 사용되지 못하거나 특정 상황에서의 적용을 제한하는 요인도 있습니다. 예를 들어, 카날로플라스티는 고도의 숙련도와 경험을 갖춘 외과의사가 필요한 섬세한 시술입니다.
모든 안과 의사가 이 시술에 능숙한 것은 아니며, 다른 많은 고난도 수술과 마찬가지로 비용이 많이 들 수 있다는 점이 환자들이 카날로플라스티를 받을 수 있도록 하는 데 제약을 줄 수 있습니다. 특히 의료 보험 혜택이 부족하거나 환자가 수술 비용을 자비로 부담해야 하는 지역이나 국가에서는 비용이 중요한 영향 요인이 될 수 있습니다.

세그먼트 분석
전 세계 카날로플라스티 치료 시장은 유형, 수술 기법, 최종 사용자 및 지역별로 세분화됩니다.
유형 세그먼트 중 미세도관 보조 카날로플라스티 세그먼트는 카날로플라스티 치료 시장 점유율의 약 41.7%를 차지했습니다.
미세도관 보조 카날로플라스티는 최소 침습 시술입니다. 큰 절개가 필요하지 않고 눈에 가해지는 외상을 줄여줍니다. 따라서 수술 후 불편함이 최소화되고 기존의 침습적인 녹내장 수술에 비해 회복 속도가 빠릅니다. 미세도관 기술과 수술 기법의 지속적인 발전으로 미세도관 보조 카날로플라스티의 결과가 더욱 개선되고 있으며, 녹내장 환자에게 점점 더 실용적인 선택지가 되고 있습니다.
또한, 새로운 제품의 출시로 해당 세그먼트의 성장이 가속화되고 있습니다. 예를 들어, 2021년 3월, 세계에서 가장 흔한 안과 질환의 근본 원인 해결에 주력하는 성장 단계의 의료기기 회사인 Sight Sciences, Inc.는 안압(IOP)을 낮추기 위해 카날로플라스티(슐렘관의 미세 카테터 삽입 및 혈관 확장술) 후 트라베쿨로토미(섬유주 절개술)를 시행하는 시술에 대해 미국 식품의약국(FDA) 510(k) 승인을 받았습니다. 이처럼 위의 요인들이 해당 부문의 성장을 촉진하고 있습니다.
지역 분석
북미는 2022년 시장 점유율의 약 38.4%를 차지했습니다.
북미는 예측 기간 동안 가장 큰 매출 점유율을 차지할 것으로 예상됩니다. 주요 시장 참여 기업의 존재, 효율적인 보험금 지급 정책, Eye America와 같은 공공 보건 프로그램, 그리고 녹내장 발병률 증가가 이 지역의 성장을 견인하고 있습니다. 예를 들어, 미국 질병통제예방센터(CDC)에 따르면 녹내장이라는 질환은 눈의 시신경을 손상시켜 시력 손실 및 실명으로 이어질 수 있습니다.
녹내장은 약 300만 명의 미국인에게 영향을 미치며, 전 세계적으로 두 번째로 흔한 실명 원인입니다. 가장 흔한 유형인 개방각 녹내장은 안압 상승을 유발합니다. 녹내장은 초기 증상이 없는 경우가 많아 환자의 50%가 자신이 녹내장을 앓고 있다는 사실을 모르고 있습니다. 의료 인프라 개선, 가처분 소득 증가, 지역 내 국내 기업의 입지 강화, 녹내장 수술 기기 보급 확대, 의료 개혁 및 기술 발전으로 인해 아시아 태평양 지역은 예측 기간 동안 상당한 매출 성장을 보일 것으로 예상됩니다.
코로나19 영향 분석
초기에는 제한 조치와 안전 문제로 인해 환자들이 치료 센터를 방문하는 데 어려움을 겪었습니다. 그러나 제한이 완화되면서 최소 침습 시술과 원격 진료 상담이 증가하면서 시장이 눈에 띄게 회복되었습니다. 제조업체와 의료 서비스 제공업체는 엄격한 안전 조치를 시행함으로써 새로운 환경에 적응했습니다. 의료 시스템이 안정화되고 환자의 신뢰가 회복됨에 따라 시장은 꾸준히 성장하고 있습니다. 향후 성장은 혁신과 환자 중심적 접근 방식에 의해 촉진될 것입니다.
경쟁 환경
시장의 주요 글로벌 업체로는 Nova Eye Medical Limited, Ellex Medical Lasers, Haag-Streit, New World Medical, Sight Sciences, Glaukos Corporation, Ophthalmic Instruments Pte Ltd., New World Medical, Inc, Ohio Eye Alliance, iScience Interventional 등이 있습니다.
주요 개발 사항
• 2021년 11월 10일, 미국 식품의약국(FDA)은 새로운 고용량 OMNI 기기("고용량 OMNI")의 안전성과 유효성을 평가하기 위한 임상 연구를 수행할 수 있도록 임상시험용 의료기기 면제(IDE)를 승인했습니다. 이 기기는 안압을 낮추기 위해 외이도 점액 확장술만 시행합니다. Sight Sciences, Inc.는 혁신적인 솔루션을 개발하여 의료 서비스 표준을 혁신하고 환자의 삶의 질을 향상시키는 데 주력하는 안과 기술 회사입니다.
보고서 구매 이유:

• 유형, 수술 기법, 최종 사용자 및 지역별 글로벌 카날로플라스티 치료 시장 세분화를 시각화하고 주요 상업 자산 및 주요 업체를 파악합니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 식별합니다.

• 모든 세그먼트를 포함한 카날로플라스티 치료 시장 수준의 다양한 데이터가 담긴 Excel 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석이 포함된 PDF 보고서를 제공합니다.

• 주요 업체들의 핵심 제품을 모두 포함하는 제품 맵핑 Excel 파일을 제공합니다.

글로벌 카날로플라스티 치료 시장 보고서는 약 61개의 표, 63개의 그림, 186페이지로 구성됩니다.
주요 대상 고객 (2023년 기준):
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 연구 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global Canaloplasty Treatment Market reached US$ YY million in 2022 and is expected to reach US$ YY million by 2030, growing with a CAGR of YY % during the forecast period 2023-2030.
Canaloplasty is a surgical procedure used to treat glaucoma, a group of eye conditions characterized by increased intraocular pressure (IOP) that can damage the optic nerve and lead to vision loss. The primary goal of canaloplasty is to lower elevated IOP, which is a major risk factor for optic nerve damage and progressive vision loss in glaucoma. By unblocking and widening the eye's natural drainage system, canaloplasty can effectively reduce IOP and help preserve vision.
Long-lasting IOP reduction from canaloplasty can help patients avoid or delay further procedures and lessen the need for frequent medication modifications. For a variety of individuals, including those with mild to moderate open-angle glaucoma who have not found relief from medication and are searching for a surgical option, canaloplasty may be an effective course of treatment. Patients who want to reduce the dangers connected with more invasive surgeries can additionally opt for it.
Market Dynamics: Drivers and Restraints
The strategies adopted by the companies
The strategies like product launches and technological developments of the products by the companies which accelerates the market growth.For instance, in April 2022, Nova Eye Medical Limited is offering the iTrack Advance, a next-generation canaloplasty device, in a few European and Asian regions. The launch of the iTrack Advance demonstrates our dedication to expanding the canaloplasty sector. The company anticipates that the release of iTrack Advance will lead to an increase in the number of cataract surgeons and general ophthalmologists performing canaloplasty procedures.
One of the main factors propelling the growth of the worldwide canaloplasty market's revenue is the rise in glaucoma cases. The number of glaucoma patients is cyclically increasing because the condition is a painless eye ailment that does not cause symptoms until there is considerable vision loss. Thus above factors boost the market growth.
Market Dynamics: Restraint
Canaloplasty has a number of positive effects but there are also certain things that can prevent it from being widely used or limit its application in specific circumstances. For instance, canaloplasty is a sensitive treatment that demands a surgeon to have a high level of competence and experience.
The availability of canaloplasty to patients may be constrained by the fact that not all eye surgeons are skilled in using this technique, and it can be costly, like many other sophisticated surgical treatments. Particularly in areas or nations with inadequate healthcare coverage or where patients must pay out-of-pocket for medical operations, the cost may be a crucial influencing factor.
Segment Analysis
The global canaloplasty treatment market is segmented based on type, surgical techniques, end-user and region.
The microcatheter-assisted canaloplasty segment from the type segment accounted for approximately 41.7% of canaloplasty treatment share
Microcatheter-assisted canaloplasty is a minimally invasive procedure. It avoids the need for major incisions and reduces trauma to the eye. This minimizes post-operative discomfort and promotes faster recovery compared to traditional, more invasive glaucoma surgeries. Ongoing advancements in microcatheter technology and surgical techniques continue to refine and improve the outcomes of microcatheter-assisted canaloplasty, making it an increasingly viable option for glaucoma patients.
Additionally, the novel products helps to accelerates the segment growth. For instance, in March 2021, Sight Sciences, Inc., a growth-stage Medical Device company focused on addressing the underlying causes of the world's most common eye conditions, the OMNI Surgical System (OMNI) had approved USFDA 510(k) clearance for canaloplasty (microcatheterization and transluminal vasodilation of Schlemm's canal) followed by trabeculotomy (cutting of trabecular meshwork) to reduce Intraocular Pressure (IOP). Thus above factors boost the segment growth.
Geographical Analysis
North America Accounted for Approximately 38.4% of the Market Share in 2022
North America is expected to account for the largest revenue share over the forecast period. Leading market players' presence, efficient reimbursement policies, and public health programs such as Eye America and rise of glaucoma helps to boost the region growth. For instance, according to CDC, a series of illnesses known as glaucoma harm the optic nerve in the eye, which can lead to vision loss and even blindness.
Glaucoma affects about 3 million Americans. It is the second most common cause of blindness in the globe. The most prevalent type of glaucoma, open-angle glaucoma, causes an increase in ocular pressure. Since glaucoma frequently has no early symptoms, 50% of those who have it are unaware that exist. Due to improvements in healthcare infrastructure, rising disposable income, the established presence of domestic companies in the region, the availability of glaucoma surgery devices, healthcare reforms, and technological advancements, Asia Pacific is predicted to experience significant revenue over the forecast period.
COVID-19 Impact Analysis
Restrictions and safety concerns initially limited patient access to treatment centers. Yet, as restrictions relaxed, there was a noticeable market recovery, emphasizing minimally invasive procedures and a rise in telemedicine consultations. Manufacturers and healthcare providers adjusted to the new circumstances by enforcing rigorous safety measures. The market's progress is steadily improving as healthcare systems stabilize and patient confidence rebounds. Future growth is fueled by innovation and a patient-focused approach.
Competitive Landscape
The major global players in the market include Nova Eye Medical Limited, Ellex Medical Lasers, Haag-Streit, New World Medical, Sight Sciences, Glaukos Corporation, Ophthalmic Instruments Pte Ltd., New World Medical, Inc, Ohio Eye Alliance, iScience Interventional and among others.
Key Developments
• In November 10, 2021, the Food and Drug Administration (FDA) approved an Investigational Device Exemption (IDE) authorising the company to conduct a clinical study to evaluate the safety and effectiveness of a new, higher volume, investigational OMNI device ("higher volume OMNI") to perform canal viscodilation alone to lower intraocular pressure. Sight Sciences, Inc. is an eyecare technology company focused on developing innovative solutions intended to transform standards of care and improve patients' lives.
Why Purchase the Report?
• To visualize the global canaloplasty treatment market segmentation based on type, surgical techniques, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of canaloplasty treatment market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global canaloplasty treatment market report would provide approximately 61 tables, 63 figures and 186 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Type
3.2. Snippet by Surgical Techniques
3.3. Snippet by End-user
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. The rise of glaucoma diseases
4.1.1.2. The strategies adopted by the companies
4.2. Restraints
4.2.1.1. High cost associated with the treatment
4.2.2. Opportunity
4.2.3. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
7.1.2. Market Attractiveness Index, By Type
7.2. Traditional Canaloplasty *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Microcatheter-assisted Canaloplasty
8. By Surgical Techniques
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Techniques
8.1.2. Market Attractiveness Index, By Surgical Techniques
8.2. Ab-interno canaloplasty *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Ab-externo canaloplasty
9. By End-user
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
9.1.2. Market Attractiveness Index, By End-user
9.2. Ophthalmology clinics *
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Hospitals
9.4. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Techniques
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Techniques
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Techniques
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Techniques
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Techniques
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Nova Eye Medical Limited *
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Ellex Medical Lasers
12.3. Haag-Streit
12.4. New World Medical
12.5. Sight Sciences
12.6. Glaukos Corporation
12.7. Ophthalmic Instruments Pte Ltd.
12.8. New World Medical, Inc
12.9. Ohio Eye Alliance
12.10. iScience Interventional
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us

언급된 주요 기업들

Nova Eye Medical Limited, 4. Key Developments, Ellex Medical Lasers, Haag-Streit, New World Medical, Sight Sciences, Glaukos Corporation, Ophthalmic Instruments Pte Ltd., New World Medical, Inc, Ohio Eye Alliance, iScience Interventional

표 목록 (Tables)

List of Tables

Table 1 Global Canaloplasty Treatment Market Value, By Type, 2022, 2026 & 2030 (US$ Million)

Table 2 Global Canaloplasty Treatment Market Value, By Surgical Techniques, 2022, 2026 & 2030 (US$ Million)

Table 3 Global Canaloplasty Treatment Market Value, By End-user, 2022, 2026 & 2030 (US$ Million)

Table 4 Global Canaloplasty Treatment Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 5 Global Canaloplasty Treatment Market Value, By Type, 2022, 2026 & 2030 (US$ Million)

Table 6 Global Canaloplasty Treatment Market Value, By Type, 2021-2030 (US$ Million)

Table 7 Global Canaloplasty Treatment Market Value, By Surgical Techniques, 2022, 2026 & 2030 (US$ Million)

Table 8 Global Canaloplasty Treatment Market Value, By Surgical Techniques, 2021-2030 (US$ Million)

Table 9 Global Canaloplasty Treatment Market Value, By End-user, 2022, 2026 & 2030 (US$ Million)

Table 10 Global Canaloplasty Treatment Market Value, By End-user, 2021-2030 (US$ Million)

Table 11 Global Canaloplasty Treatment Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 12 Global Canaloplasty Treatment Market Value, By Region, 2021-2030 (US$ Million)

Table 13 North America Canaloplasty Treatment Market Value, By Type, 2021-2030 (US$ Million)

Table 14 North America Canaloplasty Treatment Market Value, By Surgical Techniques, 2021-2030 (US$ Million)

Table 15 North America Canaloplasty Treatment Market Value, By End-user, 2021-2030 (US$ Million)

Table 16 North America Canaloplasty Treatment Market Value, By Country, 2021-2030 (US$ Million)

Table 17 South America Canaloplasty Treatment Market Value, By Type, 2021-2030 (US$ Million)

Table 18 South America Canaloplasty Treatment Market Value, By Surgical Techniques, 2021-2030 (US$ Million)

Table 19 South America Canaloplasty Treatment Market Value, By End-user, 2021-2030 (US$ Million)

Table 20 South America Canaloplasty Treatment Market Value, By Country, 2021-2030 (US$ Million)

Table 21 Europe Canaloplasty Treatment Market Value, By Type, 2021-2030 (US$ Million)

Table 22 Europe Canaloplasty Treatment Market Value, By Surgical Techniques, 2021-2030 (US$ Million)

Table 23 Europe Canaloplasty Treatment Market Value, By End-user, 2021-2030 (US$ Million)

Table 24 Europe Canaloplasty Treatment Market Value, By Country, 2021-2030 (US$ Million)

Table 25 Asia-Pacific Canaloplasty Treatment Market Value, By Type, 2021-2030 (US$ Million)

Table 26 Asia-Pacific Canaloplasty Treatment Market Value, By Surgical Techniques, 2021-2030 (US$ Million)

Table 27 Asia-Pacific Canaloplasty Treatment Market Value, By End-user, 2021-2030 (US$ Million)

Table 28 Asia-Pacific Canaloplasty Treatment Market Value, By Country, 2021-2030 (US$ Million)

Table 29 Middle East & Africa Canaloplasty Treatment Market Value, By Type, 2021-2030 (US$ Million)

Table 30 Middle East & Africa Canaloplasty Treatment Market Value, By Surgical Techniques, 2021-2030 (US$ Million)

Table 31 Middle East & Africa Canaloplasty Treatment Market Value, By End-user, 2021-2030 (US$ Million)

Table 32 Nova Eye Medical Limited: Overview

Table 33 Nova Eye Medical Limited: Product Portfolio

Table 34 Nova Eye Medical Limited: Key Developments

Table 35 Ellex Medical Lasers: Overview

Table 36 Ellex Medical Lasers: Product Portfolio

Table 37 Ellex Medical Lasers: Key Developments

Table 38 Haag-Streit: Overview

Table 39 Haag-Streit: Product Portfolio

Table 40 Haag-Streit: Key Developments

Table 41 New World Medical: Overview

Table 42 New World Medical: Product Portfolio

Table 43 New World Medical: Key Developments

Table 44 Sight Sciences: Overview

Table 45 Sight Sciences: Product Portfolio

Table 46 Sight Sciences: Key Developments

Table 47 Glaukos Corporation: Overview

Table 48 Glaukos Corporation: Product Portfolio

Table 49 Glaukos Corporation: Key Developments

Table 50 Ophthalmic Instruments Pte Ltd.: Overview

Table 51 Ophthalmic Instruments Pte Ltd.: Product Portfolio

Table 52 Ophthalmic Instruments Pte Ltd.: Key Developments

Table 53 New World Medical, Inc: Overview

Table 54 New World Medical, Inc: Product Portfolio

Table 55 New World Medical, Inc: Key Developments

Table 56 Ohio Eye Alliance: Overview

Table 57 Ohio Eye Alliance: Product Portfolio

Table 58 Ohio Eye Alliance: Key Developments

Table 59 iScience Interventional: Overview

Table 60 iScience Interventional: Product Portfolio

Table 61 iScience Interventional: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Canaloplasty Treatment Market Value, 2021-2030 (US$ Million)

Figure 2 Global Canaloplasty Treatment Market Share, By Type, 2022 & 2030 (%)

Figure 3 Global Canaloplasty Treatment Market Share, By Surgical Techniques, 2022 & 2030 (%)

Figure 4 Global Canaloplasty Treatment Market Share, By End-user, 2022 & 2030 (%)

Figure 5 Global Canaloplasty Treatment Market Share, By Region, 2022 & 2030 (%)

Figure 6 Global Canaloplasty Treatment Market Y-o-Y Growth, By Type, 2022-2030 (%)

Figure 7 Traditional Canaloplasty Treatment Market Value, 2021-2030 (US$ Million)

Figure 8 Microcatheter-assisted Canaloplasty Treatment Market Value, 2021-2030 (US$ Million)

Figure 9 Global Canaloplasty Treatment Market Y-o-Y Growth, By Surgical Techniques, 2022-2030 (%)

Figure 10 Ab-interno canaloplasty Surgical Techniques in Global Canaloplasty Treatment Market Value, 2021-2030 (US$ Million)

Figure 11 Ab-externo canaloplasty Surgical Techniques in Global Canaloplasty Treatment Market Value, 2021-2030 (US$ Million)

Figure 12 Global Canaloplasty Treatment Market Y-o-Y Growth, By End-user, 2022-2030 (%)

Figure 13 Ophthalmology clinics End-user in Global Canaloplasty Treatment Market Value, 2021-2030 (US$ Million)

Figure 14 Hospitals End-user in Global Canaloplasty Treatment Market Value, 2021-2030 (US$ Million)

Figure 15 Others End-user in Global Canaloplasty Treatment Market Value, 2021-2030 (US$ Million)

Figure 16 Global Canaloplasty Treatment Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 17 North America Canaloplasty Treatment Market Value, 2021-2030 (US$ Million)

Figure 18 Asia-Pacific Canaloplasty Treatment Market Value, 2021-2030 (US$ Million)

Figure 19 Europe Canaloplasty Treatment Market Value, 2021-2030 (US$ Million)

Figure 20 South America Canaloplasty Treatment Market Value, 2021-2030 (US$ Million)

Figure 21 Middle East and Africa Canaloplasty Treatment Market Value, 2021-2030 (US$ Million)

Figure 22 North America Canaloplasty Treatment Market Value, 2021-2030 (US$ Million)

Figure 23 North America Canaloplasty Treatment Market Share, By Type, 2022 & 2030 (%)

Figure 24 North America Canaloplasty Treatment Market Share, By Surgical Techniques, 2022 & 2030 (%)

Figure 25 North America Canaloplasty Treatment Market Share, By End-user, 2022 & 2030 (%)

Figure 26 North America Canaloplasty Treatment Market Share, By Country, 2022 & 2030 (%)

Figure 27 South America Canaloplasty Treatment Market Value, 2021-2030 (US$ Million)

Figure 28 South America Canaloplasty Treatment Market Share, By Type, 2022 & 2030 (%)

Figure 29 South America Canaloplasty Treatment Market Share, By Surgical Techniques, 2022 & 2030 (%)

Figure 30 South America Canaloplasty Treatment Market Share, By End-user, 2022 & 2030 (%)

Figure 31 South America Canaloplasty Treatment Market Share, By Country, 2022 & 2030 (%)

Figure 32 Europe Canaloplasty Treatment Market Value, 2021-2030 (US$ Million)

Figure 33 Europe Canaloplasty Treatment Market Share, By Type, 2022 & 2030 (%)

Figure 34 Europe Canaloplasty Treatment Market Share, By Surgical Techniques, 2022 & 2030 (%)

Figure 35 Europe Canaloplasty Treatment Market Share, By End-user, 2022 & 2030 (%)

Figure 36 Europe Canaloplasty Treatment Market Share, By Country, 2022 & 2030 (%)

Figure 37 Asia-Pacific Canaloplasty Treatment Market Value, 2021-2030 (US$ Million)

Figure 38 Asia-Pacific Canaloplasty Treatment Market Share, By Type, 2022 & 2030 (%)

Figure 39 Asia-Pacific Canaloplasty Treatment Market Share, By Surgical Techniques, 2022 & 2030 (%)

Figure 40 Asia-Pacific Canaloplasty Treatment Market Share, By End-user, 2022 & 2030 (%)

Figure 41 Asia-Pacific Canaloplasty Treatment Market Share, By Country, 2022 & 2030 (%)

Figure 42 Middle East & Africa Canaloplasty Treatment Market Value, 2021-2030 (US$ Million)

Figure 43 Middle East & Africa Canaloplasty Treatment Market Share, By Type, 2022 & 2030 (%)

Figure 44 Middle East & Africa Canaloplasty Treatment Market Share, By Surgical Techniques, 2022 & 2030 (%)

Figure 45 Middle East & Africa Canaloplasty Treatment Market Share, By End-user, 2022 & 2030 (%)

Figure 46 Nova Eye Medical Limited: Financials

Figure 47 Ellex Medical Lasers: Financials

Figure 48 Haag-Streit: Financials

Figure 49 New World Medical: Financials

Figure 50 Sight Sciences: Financials

Figure 51 Glaukos Corporation: Financials

Figure 52 Ophthalmic Instruments Pte Ltd.: Financials

Figure 53 New World Medical, Inc: Financials

Figure 54 Ohio Eye Alliance: Financials

Figure 55 iScience Interventional: Financials

세계 카날로플라스티 치료 시장 – 2023-2030

Global Canaloplasty Treatment Market -2023-2030